1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Latin American Pharmaceutical Market Outlook 2015-2025

Latin American Pharmaceutical Market Outlook 2015-2025

  • September 2015
  • -
  • Visiongain
  • -
  • 140 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
What can be expected from the Latin American pharmaceutical market? Which areas are going to grow at the fastest rates? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 140-page report provides 121 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See revenue forecasts for the leading international markets
How will leading national markets perform to 2025? Our study forecasts revenues in national markets including by product class for the following countries:
- Brazil
- Mexico
- Venezuela
- Argentina
- Colombia
- Chile

Leading companies and potential for market growth
Overall revenue for the Latin American pharmaceutical market will reach $87.29bn in 2018, our work forecasts. We predict strong revenue growth through to 2025. The ageing population in many of the region’s largest markets will combine with increasing investment in national health care systems to drive sales to 2025.

Our work analyses the key companies in the market. See visiongain’s analysis of 5 leading companies, including these:
- Sanofi
- EMS
- Novartis
- Pfizer
- Bayer

A company profile gives you the following information where available:
- Historical revenues from 2013 to 2014
- Discussion of a company’s activities and outlook
- Brief assessment of the companies Latin American strategy

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the Latin American pharmaceutical industry?
Our new report discusses issues and events affecting the Latin American pharmaceutical market. You will find discussions, including qualitative analyses:
- Highly diverse region needing strong knowledge of each national market
- Quickly evolving regulatory environment
- Economic weaknesses encouraging innovation

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Latin American Pharmaceutical Market Outlook 2015-2025 report helps you
In summary, our 140-page report gives you the following knowledge:
- Revenue forecasts to 2025 for the Latin American pharmaceutical market – discover the industry’s prospects, finding promising places for investments and revenues
- Revenue forecasts to 2025 for the leading regional markets – Brazil, Mexico, Venezuela, Argentina, Colombia, Chile
- Economic situation across the nations of Latin America – Understand the pressures faced across the region and how to achieve growth in an increasingly challenging environment
- Assessment of 5 leading companies – analysis of Latin American results and strategies
- Discussion of what stimulates and restrains companies and the market
- Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your resea

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    44 pages
  • Therapy  

    Serotonin Speci...  

    Antidepressant  

  • United States  

View report >

Therapy Market and Monoclonal Antibody Market in the Netherlands

  • April 2017
    13 pages
  • Therapy  

    Monoclonal Anti...  

    Targeted Therap...  

  • Netherlands  

View report >

Stroke Statistics in the US

  • April 2017
    4 pages
  • Stroke  

    Blood Disease  

  • United States  

View report >

Related Market Segments :

Pharmaceutical

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.